We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$3.79B
AUM Growth
-$394M
Cap. Flow
-$493M
Cap. Flow %
-13.02%
Top 10 Hldgs %
28.68%
Holding
753
New
220
Increased
122
Reduced
150
Closed
251

Sector Composition

Rank Sector Weight
1 Real Estate 16.29%
2 Technology 6.33%
3 Industrials 6%
4 Financials 5.96%
5 Consumer Discretionary 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLP
476
DELISTED
Valero Energy Partners LP
VLP
$340K 0.01%
8,963
-13,106
-59% -$501K
BJRI icon
477
BJ's Restaurants
BJRI
$1.44B
$334K 0.01%
4,629
-137,271
-97% -$9.21M
OPK icon
478
Opko Health
OPK
$1.25B
$310K 0.01%
89,600
-1,160,400
-93% -$6.16M
NKTR icon
479
Nektar Therapeutics
NKTR
$2.37B
$306K 0.01%
335
-332
-50% -$283K
INSM icon
480
CALL
Insmed
INSM
$22.7B
$303K 0.01%
+15,000
New +$339K
PTLA
481
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$294K 0.01%
11,040
+47
+0.4% +$1.53K
MDRX
482
DELISTED
Veradigm Inc. Common Stock
MDRX
$285K 0.01%
+20,000
New +$272K
PACB icon
483
Pacific Biosciences
PACB
$435M
$268K 0.01%
49,543
+217
+0.4% +$931
ECYT
484
DELISTED
Endocyte, Inc. Common Stock
ECYT
$266K 0.01%
+15,000
New +$258K
ABEO icon
485
Abeona Therapeutics
ABEO
$341M
$257K 0.01%
+803
New +$285K
AXDX
486
DELISTED
Accelerate Diagnostics
AXDX
$254K 0.01%
1,105
+5
+0.5% +$1.1K
UNG icon
487
United States Natural Gas Fund
UNG
$446M
$211K 0.01%
2,125
-9,500
-82% -$890K
BKS
488
DELISTED
Barnes & Noble
BKS
$203K 0.01%
35,000
CYTK icon
489
Cytokinetics
CYTK
$10.9B
$198K 0.01%
20,095
+95
+0.5% +$762
VYGR icon
490
Voyager Therapeutics
VYGR
$182M
$189K 0.01%
+10,000
New +$192K
ACH
491
Accendra Health
ACH
$239M
$182K ﹤0.01%
11,040
+47
+0.4% +$799
YELL
492
DELISTED
Yellow Corporation Common Stock
YELL
$180K ﹤0.01%
20,093
-99,949
-83% -$970K
METC icon
493
Ramaco Resources Class A
METC
$634M
$166K ﹤0.01%
22,964
-3,213
-12% -$22.5K
FTSV
494
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$149K ﹤0.01%
+10,000
New +$149K
LTS
495
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$146K ﹤0.01%
54,259
+35,000
+182% +$113K
UROV
496
DELISTED
Urovant Sciences Ltd.
UROV
$130K ﹤0.01%
+10,854
New +$128K
IMDZ
497
DELISTED
Immune Design Corp.
IMDZ
$95K ﹤0.01%
27,500
ALIM
498
DELISTED
Alimera Sciences
ALIM
$83K ﹤0.01%
5,626
+18
+0.3% +$274
AVEO
499
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$50K ﹤0.01%
+1,500
New +$38.6K
CRIS icon
500
Curis
CRIS
$9.49M
$47K ﹤0.01%
67
+1
+2% +$651

Similar funds

Weiss Multi-Strategy Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Weiss Multi-Strategy Advisers held 753 positions worth $3.79B, down 9.4% from $4.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $493M in Q3 2018, closing 251 positions and reducing 150 holdings. Its most notable exit was Boston Properties, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Extra Space Storage worth $36.8M.

  • Weiss Multi-Strategy Advisers's largest Q3 2018 buy was Extra Space Storage: 425,000 shares worth $36.8M.
  • Weiss Multi-Strategy Advisers added most to Kilroy Realty in Q3 2018, an estimated $37.9M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2018 reduction was Liberty Property Trust, cutting an estimated $40.2M.
  • Weiss Multi-Strategy Advisers fully exited Boston Properties in Q3 2018, selling an estimated $66.5M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 29% of its $3.79B portfolio in Q3 2018.
  • Weiss Multi-Strategy Advisers opened 220 new positions and closed 251 in Q3 2018.
  • Weiss Multi-Strategy Advisers's portfolio value fell 9.4% quarter-over-quarter to $3.79B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.